Industry Leaders Discuss Identifying and Dealing With Drug Diversion

September 16, 2020

Establishing a drug diversion monitoring program is key for healthcare providers to prevent violations from causing harm. Without a strategy, patients, providers, the organization, and even the diverters themselves can face irreversible consequences.

In this video by Healthcare Innovation, two drug diversion experts – LifeBridge Health's Lisa Polinsky, Assistant VP of Pharmacy Services and FairWarning's Kara Earle, Senior Drug Diversion Specialist – weigh in on key issues related to prescription medicines being obtained or used illegally.

Tune in to hear their insights for identifying and remediating drug diversion cases, the steps for establishing robust drug diversion monitoring programs at patient care facilities, and more.

Previous Article
11 Salesforce Data Security Threats Uncovered by Risk Assessments
11 Salesforce Data Security Threats Uncovered by Risk Assessments

Discover 11 Salesforce data security threats organizations discovered with real findings from FairWarning's...

Next Article
Cloud Security Roundup: New Guidelines for Zero Trust Architecture, the Cost of Cybercrime, and More
Cloud Security Roundup: New Guidelines for Zero Trust Architecture, the Cost of Cybercrime, and More

Discover the latest cloud security news, including new zero trust architecture guidelines, CISO priorities,...